Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1983 | 1 |
2005 | 1 |
2012 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
A scoping review of lung function in children and adolescents living with HIV in the era of antiretroviral treatment.
Pediatr Pulmonol. 2023 May;58(5):1344-1354. doi: 10.1002/ppul.26365. Epub 2023 Mar 21.
Pediatr Pulmonol. 2023.
PMID: 36811157
Review.
BACKGROUND: Human immunodeficiency virus (HIV) in children and adolescents remains an important health challenge in many countries and is commonly associated with lung disease. The introduction of antiretroviral therapy (ART) has greatly improved survival but chronic lung …
BACKGROUND: Human immunodeficiency virus (HIV) in children and adolescents remains an important health challenge in many countries and is co …
Validation of potential classification criteria for systemic sclerosis.
Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA Jr, Peschken CA, Carreira PE, Riemekasten G, Tyndall A, Matucci-Cerinic M, Pope JE.
Johnson SR, et al.
Arthritis Care Res (Hoboken). 2012 Mar;64(3):358-67. doi: 10.1002/acr.20684.
Arthritis Care Res (Hoboken). 2012.
PMID: 22052658
Free PMC article.
OBJECTIVE: Classification criteria for systemic sclerosis (SSc; scleroderma) are being updated jointly by the American College of Rheumatology and European League Against Rheumatism. Potential items for classification were reduced to 23 using Delphi and nominal group techn …
OBJECTIVE: Classification criteria for systemic sclerosis (SSc; scleroderma) are being updated jointly by the American College of Rheumatolo …
Item in Clipboard
Rituximab in the treatment of dermatomyositis: an open-label pilot study.
Levine TD.
Levine TD.
Arthritis Rheum. 2005 Feb;52(2):601-7. doi: 10.1002/art.20849.
Arthritis Rheum. 2005.
PMID: 15692974
Free article.
Two patients maintained their increased muscle strength at 52 weeks, and 1 of these patients maintained this strength even after the return of B cells. Other symptoms of DM, including rash, alopecia, and reduced forced vital capacity, improved markedly …
Two patients maintained their increased muscle strength at 52 weeks, and 1 of these patients maintained this strength even after the return …
Item in Clipboard
The exclusion of restrictive lung disease by spirometric criteria in patients with a reduced forced vital capacity.
Eichenhorn MS, Popovich J Jr, Beauchamp RK, Armstrong J, Ward JC.
Eichenhorn MS, et al.
Henry Ford Hosp Med J. 1983;31(2):101-3.
Henry Ford Hosp Med J. 1983.
PMID: 6629833
Free article.
No abstract available.
Item in Clipboard
Cite
Cite